| Title | Cancer Genomics and Proteomics |
| Abbreviation | Cancer Genom. Proteom. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biochemistry (Q2); Medicine (miscellaneous) (Q2); Cancer Research (Q3); Genetics (Q3); Molecular Biology (Q3) |
| h-index | 46 |
| Overall Rank/Ranking | 7667 |
| SCImago Journal Rank (SJR) | 0.660 |
| Impact Score | 2.58 |
| Publisher | International Institute of Anticancer Research |
| Country | Greece |
| ISSN | 17906245, 11096535 |
| Best Quartile | Q2 |
| Coverage History | 2004-2022 |
Cancer Genomics & Proteomics (CGP) is an international journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer research. In this site you may find information concerning the editorial board, editorial policy, issue contents, subscriptions, submission of manuscripts and advertising. The first issue of CGP circulated in January 2004.
Cancer Genomics & Proteomics is published bimonthly by the International Institute of Anticancer Research.
Cancer Genomics & Proteomics supports (a) the aims and the research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH.
Cancer Genomics and Proteomics is a journal covering the technologies/fields/categories related to Biochemistry (Q2); Medicine (miscellaneous) (Q2); Cancer Research (Q3); Genetics (Q3); Molecular Biology (Q3). It is published by International Institute of Anticancer Research. The overall rank of Cancer Genomics and Proteomics is 7667. According to SCImago Journal Rank (SJR), this journal is ranked 0.660. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 46. The best quartile for this journal is Q2.
The ISSN of Cancer Genomics and Proteomics journal is 17906245, 11096535. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Genomics and Proteomics is cited by a total of 527 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Cancer Genomics and Proteomics is 2.58, which is computed in 2023 as per its definition. Cancer Genomics and Proteomics IF is decreased by a factor of 0.9 and approximate percentage change is -25.86% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Cancer Genomics and Proteomics is 2.58. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.58 |
| 2021 | 3.48 |
| 2020 | 4.22 |
| 2019 | 3.42 |
| 2018 | 3.41 |
| 2017 | 2.55 |
| 2016 | 2.12 |
| 2015 | 3.22 |
| 2014 | 3.30 |
Cancer Genomics and Proteomics has an h-index of 46. It means 46 articles of this journal have more than 46 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Genomics and Proteomics is 17906245, 11096535. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Genomics and Proteomics is 7667. According to SCImago Journal Rank (SJR), this journal is ranked 0.660. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.660 |
| 2021 | 0.748 |
| 2020 | 1.234 |
| 2019 | 1.039 |
| 2018 | 0.991 |
| 2017 | 0.818 |
| 2016 | 0.996 |
| 2015 | 1.109 |
| 2014 | 1.285 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 7667 |
| 2021 | 6282 |
| 2020 | 3146 |
| 2019 | 4070 |
| 2018 | 4416 |
| 2017 | 5674 |
| 2016 | 4455 |
| 2015 | 3822 |
| 2014 | 2974 |
Cancer Genomics and Proteomics is published by International Institute of Anticancer Research. It's publishing house is located in Greece. Coverage history of this journal is as following: 2004-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Genomics and Proteomics is Cancer Genom. Proteom.. This abbreviation ('Cancer Genom. Proteom.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biochemistry (Q2); Medicine (miscellaneous) (Q2); Cancer Research (Q3); Genetics (Q3); Molecular Biology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer Genomics and Proteomics latest impact IF is 2.58. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 4.22 (2020) and 2.12 (2016), respectively, in the last 9 years. Moreover, its average IS is 3.14 in the previous 9 years.
The Cancer Genomics and Proteomics has an SJR (SCImago Journal Rank) of 0.660, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.285 in 2014 and the lowest being 0.660 in 2022. Furthermore, the average SJR of the Cancer Genomics and Proteomics over the previous 9-year period stands at 3.14.
The latest h-index of the Cancer Genomics and Proteomics is 46.
The Cancer Genomics and Proteomics is published by the International Institute of Anticancer Research, with its country of publication being the Greece.
The Cancer Genomics and Proteomics is currently ranked 7667 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 2974 in 2014 and its lowest position of 7667 in 2022.
The standard ISO4 abbreviation for the Cancer Genomics and Proteomics is Cancer Genom. Proteom..
Cancer Genomics and Proteomics is classified as a journal that the International Institute of Anticancer Research publishes.
The Cancer Genomics and Proteomics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Genomics and Proteomics is assigned the following International Standard Serial Numbers (ISSN): 17906245, 11096535.
The best quartile for the Cancer Genomics and Proteomics is Q2 (2022).
The Cancer Genomics and Proteomics coverage history can be summarized as follows: 2004-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8920 | Springer Netherlands | 26 | 2.28 |
| Journal of Business Finance and Accounting | journal | 3221 | Wiley-Blackwell Publishing Ltd | 84 | 3.68 |
| Materials Research | journal | 14791 | Universidade Federal de Sao Carlos | 65 | 1.62 |
| Proceedings of the Technical Association of the Graphic Arts, TAGA | conference and proceedings | 30903 | Technical Association of the Graphic | 8 | 0.00 |
| Metascience | journal | 13645 | Springer Nature | 3 | 0.13 |
| Agroalimentaria | journal | 19317 | Centro de Investigaciones Agroalimentarias (CIAAL- | 8 | 0.20 |
| Asian Journal of Animal and Veterinary Advances (discontinued) | journal | 15083 | Academic Journals Inc. | 28 | 3.00 |
| Society and Economy | journal | 18366 | Akademiai Kiado | 15 | 0.93 |
| Brain Imaging and Behavior | journal | 4198 | Springer New York | 62 | 3.56 |
| Analytical Chemistry Insights | journal | 6696 | Libertas Academica Ltd. | 20 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.58 |
| 2021 | 3.48 |
| 2020 | 4.22 |
| 2019 | 3.42 |
| 2018 | 3.41 |
| 2017 | 2.55 |
| 2016 | 2.12 |
| 2015 | 3.22 |
| 2014 | 3.30 |
